Camela, E., Villani, A., Ocampo Garza, S. S., Costa, C., Fabbrocini, G., Megna, M., Potestio, L., Ruggiero, A., & Scalvenzi, M. (2023). Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire. Dermatology Practical & Conceptual, 13(3), e2023177. https://doi.org/10.5826/dpc.1303a177